iCSE brings together Japanese and international outsourcing companies & acts as a platform to connect with the pharma industry. The ICSE exhibitors offer a wide variety of outsourcing services, including clinical trials, IT, research, biotechnological, logistical and analytical services.
The market for contract manufacturing of products outside of Japan for launch inside is likely to grow quickly – and Europe would seem a good option to supplement reductions in costs and growing volumes. With regulatory approvals in Japan amongst the fastest, global contract manufacturers that have site approvals for the EU, USA and Japan may be the biggest beneficiaries*.
* source: What does 2019 hold for Japan? The world's most ambivalent pharma market
Attending the event was a good chance to get in contact with Japanese companies and to understand the Japanese pharma industry and trends. We are looking forward to attending this wonderful exhibition again and to exchange our experience with local Japanese companies.”